Eversana has established a data and analytics business and appointed Brigham Hyde as president of.
Data from a COVID-19 trial of Gilead’s remdesivir showed no benefit. The antiviral drug did.
The government is planning to assist hospitals and doctors who provide care for uninsured patients.
IPG’s head has warned that Q1 results “cannot be indicative of the remainder of the.
As the COVID-19 pandemic keeps the industry in a state of flux, Fingerpaint has started.
To better understand how physicians are responding to the tectonic changes prompted by the coronavirus.
Amid the COVID-19 pandemic, patient community leader Wego Health held a Zoom conference with chronic.
Gilead’s remdesivir has shown early promise treating COVID-19 patients. Patients involved in the clinical trial have.
In the business of healthcare, the level of care you provide will always be the.
Direct mail is not dead. At a time when email inboxes are overflowing, how else.